	CAR cellular therapies for acute myeloid leukemia: current landscape and future directions. Immunotherapy Hederih J, Patrick J, Gannon I, Rampotas A, Roddie C, Sellar R. PMID: 42319045 [PubMed - as supplied by publisher]
	PI3KÎ´ inhibitor YYâ€‘20394 is effective alone or in combination with Bclâ€‘2 inhibitor ABT199 in acute myeloid leukemia cells. Oncol Rep Geng Y, Zhou L, Lou Y, Chen J, Liu Q, Shen J, Yang Y, Wu W. PMID: 42318952 [PubMed - indexed for MEDLINE]
	Burkitt`s Lymphoma Presenting as Ileocolic Intussusception in a 8 year old boy. Kathmandu Univ Med J (KUMJ) Basnet D, Makaju R, Gautam N, Shrestha B, Sharma S. PMID: 42318739 [PubMed - indexed for MEDLINE]
	Impact of reader experience on the time-saving potential of a novel computer-aided tool for Ann Arbor staging of pediatric hodgkin lymphoma. Front Nucl Med Vasyliv I, Barrow MJ, Baratto L, Kim HG, von Krüchten VR, Lokesha YU, Sarrami AH, Moeremans M, Guja KE, Hawk KE, Daldrup-Link HE. PMID: 42318441 [PubMed]
	Liquid biopsy for molecular profiling in cutaneous T-cell lymphoma: a pilot feasibility study. Blood Neoplasia Sacknovitz Y, Erem AS, Kent JA, Albitar M, Feldman T, Pro B, Tolu SS, Gru AA, Geskin L. PMID: 42317601 [PubMed]
	Clinical Profile and Chemotherapy Outcomes of Adult Lymphoma Patients at Jimma University Medical Center: A 2-Year Retrospective Study. EJHaem Gutema KC, Dekema RJ, Gudiso RK, Guji AA, Ahmed MD, Fikremaram DG, Kebede ML, Genet ST, Tukeni KN. PMID: 42317402 [PubMed]
	Impact of TP53 mutations on survival outcomes in the CAR-T era of large B-cell lymphoma. Front Immunol Liu R, Fu Z, Yang F, Cao M, Ma L, Guo Y, Deng B, Zheng Q, Chen C, Jiang B, Chang AH, Li D, Ke X, Hu K. PMID: 42317374 [PubMed - indexed for MEDLINE]
	Phase 3 PERSPECTIVE study: Ibrutinib with rituximab for initial treatment of patients with follicular lymphoma. Hemasphere Belada D, Gardner FP, de Oliveira AC, Sancho JM, Lomaia E, Wright D, Turgut M, Martynova E, Lázár Z, Anz B, Wang MC, Legiec W, Opat S, Pailden J, Peltier HM, Marturano E, Dean JP, Flinn IW. PMID: 42317205 [PubMed]
	IGNITE: a phase III study of tirabrutinib versus rituximab and temozolomide combination therapy in relapsed/refractory primary central nervous system lymphoma. Future Oncol Nayak L, Grommes C, Psoinos C, Reu FJ, Takazawa A, Uttarwar M, Xia B, Carvajal LA, Kim S, Sherman ML, Batchelor TT. PMID: 42317052 [PubMed - as supplied by publisher]
	Ultrasound as a robust tool for lymph node staging in cutaneous T-cell lymphoma. J Dtsch Dermatol Ges Wen Y, Liu C, Wang W, Li X, Chen Z, Xiao Y, Wang H, Jiang Y, Cao M, Li M, Deng R, Dang J, Cui Z, Yang C, Sun J, Chen L, Wang Y. PMID: 42316933 [PubMed - as supplied by publisher]
	Diagnosis of Skin Parasites, Bacteria, and Fungi and Their Impact on Hematological Parameters in Patients with T-LGL Leukemia. Infect Disord Drug Targets Al-Ubaidi NAH, Kadhim SK, Farhood ZH. PMID: 42316503 [PubMed - as supplied by publisher]
	Familial lymphoma and genetic predisposition: an updated review. BMC Med Genomics Braun L, Graffeo R, Kapilan K, Mandhair HK, Rabaglio M, Novak U. PMID: 42316213 [PubMed - as supplied by publisher]
	Central nervous system penetration of imatinib in acute lymphoblastic leukemia: Pharmacokinetic analysis and clinical implications. Cancer Chemother Pharmacol Rasmussen ASB, Rank CU, Christensen IJ, Weimann A, Hansen K, Thastrup M, Yang T, Lund TM, Wik HS, Vogt H, Norén-Nyström U, Vaitkeviciene G, Albertsen BK, Wehner PS, Als-Nielsen B, Andersen CL, Dalhoff K, Schmiegelow K. PMID: 42315664 [PubMed - indexed for MEDLINE]
	Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study. Leukemia Rinaldetti S, Chepeleva M, Hedblom A, Sticht C, Muciek M, Panayiotidis P, Richter J, Olsson-Strömberg U, Nowak D, Nowak V, Ljungman P, von Bubnoff N, Lotfi K, Stenke L, Brümmendorf TH, Hjorth-Hansen H, Gedde-Dahl T, Majeed W, Burchert A, Nazarov PV, Felde E, Tarnopolscaia I, Hoelting C, Fabarius A, Hofmann WK, Mahon FX, Saussele S, Pfirrmann M. PMID: 42315627 [PubMed - as supplied by publisher]
	[Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)]. Bull Cancer Delafoy M, Vincenti M, Roussel A, Prigent S, Rialland F, Doulet ST, Hauet Q, Broccia MV, Rabian F, Poirée M, Tabone MD, El-Louali F, Saultier P. PMID: 42315465 [PubMed - as supplied by publisher]
	Dosimetric evaluation of beam block techniques in helical tomotherapy for extranodal nasal-type NK/T-cell lymphoma. Med Dosim Zhu L, Zhang B, He Q, Yang G, Jin H, Li F, Meng H, Jian W, Wang X. PMID: 42315453 [PubMed - as supplied by publisher]
	Evaluation of Baseline and Interim-Therapy PET Features for Prognostication in High-Risk Pediatric Hodgkin Lymphoma: A Retrospective Analysis of the AHOD1331 Trial. J Nucl Med Tie X, Lee C, Perlman SB, Gowdy C, Shin M, Renfro LA, Kelly KM, McCarten KM, Alazraki AL, Voss SD, Alizadeh AA, Castellino SM, Bradshaw TJ, Cho SY. PMID: 42315307 [PubMed - as supplied by publisher]
	A multicenter randomized phase II/III trial of salvage treatment for refractory primary central nervous system lymphoma using tirabrutinib: JCOG2314 (ReSTART). Jpn J Clin Oncol Kawabata K, Ohka F, Saito R, Onoe T, Harada H, Sasayama T, Yokoo H, Arakawa Y, Mizusawa J, Mitome N, Sasaki K, Fukuda H, Narita Y, Brain Tumor Study Group of the Japan Clinical Oncology Group. PMID: 42315131 [PubMed - as supplied by publisher]
	Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline. JCO Oncol Pract Lockwood CM, Messersmith HJ, Kim AS, Rajagopal PS, Swami U, Xian R, Aisner D, Arcila ME, Kurttila F, Lovly CM, Merker JD, Nair KG, Ntekim AI, Sheen MA, Tsimberidou AM, Turner NC, Gray SW. PMID: 42314080 [PubMed - as supplied by publisher]
	Anti-CD19 CAR-T in transformed indolent lymphoma versus de novo large B-cell lymphoma: a meta-analysis of 5,006 patients. Blood Adv Zhang MY, Lu KJ, Zhu XQ, Shen LJ, Du J. PMID: 42314038 [PubMed - as supplied by publisher]

Articles 1 - 20 / 168390

Page 1 of 8420



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy